We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+17.77%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
AUM
$74.4M
AUM Growth
-$7.7M
Cap. Flow
-$18.1M
Cap. Flow %
-24.3%
Top 10 Hldgs %
31.3%
Holding
122
New
27
Increased
23
Reduced
27
Closed
36

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$1.5M
2
NOW icon
ServiceNow
NOW
+$1.34M
3
DXC icon
DXC Technology
DXC
+$1.33M
4
MSFT icon
Microsoft
MSFT
+$1.31M
5
AMZN icon
Amazon
AMZN
+$1.27M

Sector Composition

Rank Sector Weight
1 Healthcare 52.74%
2 Technology 15.35%
3 Miscellaneous 14.63%
4 Consumer Discretionary 6.1%
5 Communication Services 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KITE
1
DELISTED
Kite Pharma, Inc.
KITE
$2.99M 4.02%
28,837
+15,324
+113% +$1.25M
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.94M 3.94%
52,269
+16,907
+48% +$677K
XLV icon
3
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$2.76M 3.71%
+34,800
New +$2.65M
PBYI icon
4
Puma Biotechnology
PBYI
$468M
$2.56M 3.44%
29,282
+11,668
+66% +$653K
ELV icon
5
Elevance Health
ELV
$85.5B
$2.36M 3.17%
12,534
+1,897
+18% +$341K
BABA icon
6
Alibaba
BABA
$296B
$2.19M 2.94%
15,541
-1,426
-8% -$176K
GDDY icon
7
GoDaddy
GDDY
$12.4B
$1.98M 2.65%
46,566
+9,279
+25% +$372K
UHS icon
8
Universal Health Services
UHS
$10.1B
$1.84M 2.48%
15,117
+270
+2% +$32.1K
QQQ icon
9
PUT
Invesco QQQ Trust
QQQ
$489B
$1.83M 2.46%
+13,300
New +$1.83M
HUM icon
10
Humana
HUM
$46.3B
$1.83M 2.45%
7,591
-1,724
-19% -$390K
MSFT icon
11
Microsoft
MSFT
$3.81T
$1.79M 2.41%
25,984
+19,067
+276% +$1.31M
PCRX icon
12
Pacira BioSciences
PCRX
$1.03B
$1.72M 2.31%
36,119
+1,906
+6% +$88.4K
AERI
13
DELISTED
Aerie Pharmaceuticals
AERI
$1.71M 2.29%
32,496
+5,207
+19% +$242K
EW icon
14
Edwards Lifesciences
EW
$52B
$1.65M 2.21%
41,814
+8,769
+27% +$320K
MCK icon
15
McKesson
MCK
$104B
$1.63M 2.19%
+9,888
New +$1.5M
BAX icon
16
Baxter International
BAX
$13.5B
$1.62M 2.18%
26,755
-1,330
-5% -$75.5K
NOW icon
17
ServiceNow
NOW
$150B
$1.45M 1.95%
+68,350
New +$1.34M
CI icon
18
Cigna
CI
$73.7B
$1.38M 1.85%
8,222
+1,103
+15% +$177K
UNH icon
19
UnitedHealth
UNH
$353B
$1.38M 1.85%
7,421
-152
-2% -$26.7K
MDCO
20
DELISTED
Medicines Co
MDCO
$1.36M 1.82%
35,720
-2,983
-8% -$133K
DXC icon
21
DXC Technology
DXC
$1.79B
$1.32M 1.78%
+19,970
New +$1.33M
AMZN icon
22
Amazon
AMZN
$2.87T
$1.29M 1.74%
+26,700
New +$1.27M
MOH icon
23
Molina Healthcare
MOH
$10.4B
$1.27M 1.7%
18,293
+7,144
+64% +$438K
ABT icon
24
Abbott
ABT
$195B
$1.21M 1.63%
+24,895
New +$1.13M
V icon
25
Visa
V
$712B
$1.16M 1.56%
12,414
+6,421
+107% +$596K

Similar funds

Partner Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Partner Investment Management held 122 positions worth $74.4M, down 9.4% from $82.1M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Partner Investment Management withdrew a net $18.1M in Q2 2017, closing 36 positions and reducing 27 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 47% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Partner Investment Management opened a new position in McKesson worth $1.63M.

  • Partner Investment Management's largest Q2 2017 buy was McKesson: 9,888 shares worth $1.63M.
  • Partner Investment Management added most to Microsoft in Q2 2017, an estimated $1.31M increase.
  • Partner Investment Management's biggest Q2 2017 reduction was Marvell Technology, cutting an estimated $2.44M.
  • Partner Investment Management fully exited Jazz Pharmaceuticals in Q2 2017, selling an estimated $2.3M.
  • Partner Investment Management's ten largest holdings make up 31% of its $74.4M portfolio in Q2 2017.
  • Partner Investment Management opened 27 new positions and closed 36 in Q2 2017.
  • Partner Investment Management's portfolio value fell 9.4% quarter-over-quarter to $74.4M.

Based on Partner Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.